Management of Complete Heart Block

First-Line Management

The American Heart Association recommends atropine as the initial pharmacological intervention for symptomatic complete heart block, particularly when the block is believed to be at the AV nodal level, with a dosing of 0.3-0.5 mg IV initially, repeated every 3-5 minutes up to a maximum total dose of 1.5-2.0 mg 1, 2, 3, 4
Atropine improves AV conduction, increases ventricular rate, and improves symptoms in AV nodal-level blocks 1, 2, 3

Beta-adrenergic agonists, including epinephrine, may be considered as second-line therapy when atropine has failed and the patient has a low likelihood for coronary ischemia, with epinephrine having stronger beta-1 effects that directly improve AV conduction and increase ventricular rate 1, 2, 3, 5
The American College of Cardiology states that norepinephrine primarily acts on alpha-receptors for vasoconstriction with less consistent chronotropic effects, making it less suitable for improving conduction 6

Temporary transvenous pacing is reasonable for complete heart block with symptoms or hemodynamic compromise refractory to medical therapy, with a Class IIa recommendation 1, 2, 3, 5
Permanent pacing is a Class I indication for symptomatic third-degree AV block 7

The American Heart Association recommends avoiding beta-agonists as first-line therapy and instead trying atropine first 1, 2, 3, 5
Beta-agonists should not be used in acute MI with complete heart block due to increased myocardial oxygen demand 5
Temporary pacing should not be delayed while attempting multiple pharmacological interventions, as pacing is more definitive and safer 1, 2, 3, 5